(Total Views: 102)
Posted On: 05/18/2021 8:05:47 AM
Post# of 145174

$SMMT News Article - Summit Therapeutics Announces Preclinical Candidate and Associated CARB-X Funding Support for the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae, a CDC Urgent Threat and WHO Critical Priority https://marketwirenews.com/news-releases/summ...17639.html


My Twitter: WhyteStocks